RA0094

antibody from Oursmab

Targeting: CD38

Western blot (Supportive data in Antibodypedia)

ELISA (Data presented on provider website)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0094

Provider

Oursmab

Product name

Daratumumab (Biosimilar Reference Antibody) (CD38)

Antibody type

Monoclonal

Description

Daratumumab is a fully human monoclonal antibody that targets the CD38 protein and is a cornerstone therapy for multiple myeloma. Marketed under the brand name Darzalex?, it was the first CD38-directed antibody approved for this disease. It is used across multiple lines of treatment, from newly diagnosed to heavily relapsed/refractory myeloma, both as a monotherapy and in combination with standard regimens (such as immunomodulatory drugs, proteasome inhibitors, and corticosteroids). Its approval has significantly improved response rates and survival outcomes for patients.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

Western blot

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

Daratumumab (Biosimilar Reference Antibody) (CD38)-RA0094-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.